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molecules (Grabowska et al., 2001; He et al., 1999). Gen-
eration of HCV-specific CD8 CTL lines from the liver
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dependent RNA polymerase that lacks a proofreadingSummary
mechanism (Bukh et al., 1995) appears to favor Darwin-
ian selection of variant viruses by humoral and cellularCD8 cytotoxic T lymphocytes (CTL) are thought to
immune responses (Manzin et al., 2000). Dominant B cellcontrol hepatitis C virus (HCV) replication and so we
epitope(s) located in the hypervariable region 1 (HVR-1)investigated why this response fails in persistently in-
of envelope glycoprotein 2 (E2) mutate and this wasfected individuals. The HCV quasispecies in three per-
recently linked to persistence of HCV infection (Farci etsistently infected chimpanzees acquired mutations in
al., 2000). Mutation of class I or II MHC restricted epi-multiple epitopes that impaired class I MHC binding
topes could also alter the outcome of infection by pre-and/or CTL recognition. Most escape mutations ap-
venting or delaying clearance of infected hepatocytespeared during acute infection and remained fixed in
by T lymphocytes (Eckels et al., 2000). Amino acid sub-the quasispecies for years without further diversifica-
stitutions that inhibit CD8 CTL recognition have beention. A statistically significant increase in the amino
observed in the HCV quasispecies from chimpanzeesacid replacement rate was observed in epitopes ver-
(Weiner et al., 1995) and humans (Chang et al., 1997;sus adjacent regions of HCV proteins. In contrast,
Kaneko et al., 1997; Tsai et al., 1998) with chronic hepati-most epitopes were intact when hepatitis C resolved
tis C. The role of these mutations in establishing andspontaneously. We conclude that CTL exert positive
maintaining the persistent state remains controversial.selection pressure against the HCV quasispecies and
One argument against this mechanism is that mutationthe outcome of infection is predicted by mutations in
of several epitopes, perhaps simultaneously, would be
class I MHC restricted epitopes.
required for survival of the virus in the face of a multispe-
cific CTL response. Statistical evidence for positive se-
Introduction lection pressure against multiple class I MHC restricted
epitopes is also lacking in chronic HCV infection.
Spontaneous resolution of hepatitis C virus (HCV) infec- Animal models are useful for investigating escape mu-
tion is kinetically associated with a robust, durable cyto- tations because the nucleotide sequence of the chal-
toxic T lymphocyte (CTL) response targeting multiple lenge virus is known and genetic polymorphism within
HCV epitopes (Cooper et al., 1999; Gruner et al., 2000; the MHC complex can be controlled. Recent studies in
Lechner et al., 2000b; Takaki et al., 2000). Why this re- a family of SIV-infected rhesus macaques provided the
sponse fails to contain HCV replication in 70%–80% of first convincing proof that positive selection pressure
the individuals who develop persistent viremia is not by CD8 CTL drives mutation in class I MHC restricted
clear. Chronic infection is characterized by low frequen- epitopes in lentivirus infections (Evans et al., 1999). We
cies of CD8 T cells in peripheral blood (Battegay et al., recently reported that spontaneous resolution of acute
1995; Cerny et al., 1995; He et al., 1999; Hiroishi et al., hepatitis C in chimpanzees was kinetically associated
1997; Rehermann et al., 1996; Shirai et al., 1994), but with an intrahepatic CD8 T cell response targeting mul-
they are not necessarily absent from the liver. Indeed, tiple HCV epitopes (Cooper et al., 1999). The goal of
HCV-specific CTL were detected at higher frequencies this study was to compare viruses from animals with
resolved and chronic HCV infections for evidence of
immune selection pressure.6 Correspondence: walkerc@pediatrics.ohio-state.edu
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Figure 1. Class I MHC Haplotypes and Epitopes Targeted by Chimpanzees with Acute Resolving and Chronic Hepatitis C
Results was fixed in the quasispecies mastercopy (Figure 2A).
The position seven (P7) isoleucine (I1635) to threonine
(T) substitution in this epitope prevented target cell lysisEpitope Variation in a Self-Limited HCV Infection
Spontaneous resolution of acute hepatitis C in chimpan- by CTL lines generated from the liver of CH-497 at weeks
78 (Figure 2B) and 11 (Figure 2C) postchallenge. Thesezee CH-497 (Todd) was observed approximately 11
weeks after experimental challenge with the HCV-1/910 data suggest that escape mutations could arise rapidly
in a limited subset of epitopes in individuals with acutevirus (Cooper et al., 1999). CTL targeting most structural
and nonstructural HCV proteins were detected in serial resolving hepatitis C. However, at least in this case,
resolution was associated with a multispecific responseliver samples immediately before termination of viremia
and through 96 weeks of follow-up. CD8 T cell clones targeting seven other epitopes that did not change.
derived from liver at weeks 11 and 78 postinfection rec-
ognized eight different epitopes presented by Patr- Evolution of CTL Epitopes in Chronic Infection
We predicted that persistent HCV replication was facili-class I A, B, and C molecules (Cooper et al., 1999) (see
Figures 1A and 1B). HCV RNA isolated from a plasma tated by mutation of multiple class I MHC restricted
epitopes. Therefore, the evolution of HCV epitopes wassample taken at week 7 immediately before clearance
of viremia (Cooper et al., 1999) was examined for muta- studied in three chimpanzees chronically infected with
HCV-1/910 for several years. They included CBO603tions in these epitopes. Sequencing of multiple molecu-
lar clones revealed that only the Patr-B1701 restricted (Briggsie), CBO609 (Hulk), and CH503 (Ross).
HCV-specific CTL lines derived from the liver or bloodNS31629 epitope (GAVQNEITL) contained a mutation that
Mutation of CTL Epitopes Predicts HCV Persistence
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Figure 2. Sequence of Epitopes in Resolved HCV Infection
A plasma sample was collected from CH-497 at week 7 postinfection, the last time point positive for HCV RNA before infection was terminated
at week 11 postinfection (Cooper et al., 1999).
(A) Seven regions of the HCV genome encoding eight different CTL epitopes targeted by this animal were amplified by PCR and multiple
molecular clones were sequenced. The deduced amino acid sequence of genomes and their frequency are shown. Epitopes are highlighted.
(B) CTL line generated from liver at 78 weeks postinfection was tested for recognition of the NS31629 epitope or the I1635T variant.
(C) CTL line generated from liver at 11 weeks postinfection was tested for recognition of the NS31629 epitope or the I1635T variant.
of chimpanzee CBO609 after 5 years of chronic infection T cells expanded from the liver of CBO609 (Hulk) be-
tween weeks 14 and 36 postinfection killed target cellstargeted at least five discrete epitopes located in E2
and nonstructural proteins 2, 3, and 4, of the HCV-1/ expressing NS3 and NS4 but not other structural or
nonstructural proteins (Cooper et al., 1999). Interest-910 virus. The sequence and MHC restriction of these
epitopes are shown in Figure 3A. Significantly, all four ingly, this CTL activity was predominantly restricted by
the Patr-B1701 class I molecule (data not shown) thatepitopes examined contained mutations by month 4
(week 16) postinfection that were still fixed in the quasi- presented two of the mutated epitopes (NS31629 and
NS41939) (Figure 3A). Thus, mutation of NS3 and NS4species approximately 5 years later (Figure 3A). Muta-
tion of these epitopes was also temporally associated epitopes during the first 16 weeks of infection (Figure 3A)
coincided with potent but narrowly focused intrahepaticwith a narrowly focused intrahepatic CTL response
(Cooper et al., 1999). We previously reported that CD8 CTL activity.
Immunity
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Figure 3. Evolution of Class I MHC Restricted Epitopes in Three Chronically Infected Chimpanzees
HCV RNA genomes extracted from serial plasma samples at the indicated time points were amplified by PCR and multiple molecular clones
were sequenced and compared with the HCV-1/910 consensus (top row). All epitopes displaying variant sequences are shown. The number
of clones of each representative sequence is shown in brackets.
Mutation of epitopes in the other two animals oc- NS31446 (GDFDSVIDC) was intact after 1 month of virus
replication in this animal (Weiner et al., 1995). However,curred sequentially during the first few months of virus
replication. CTL lines generated from the blood and liver by month 4, a P4 aspartic acid (D1449) to glutamic acid
(E) mutation (D1449E) was fixed in the HCV quasispeciesof chimpanzee CH-503 (Ross) at month 82 targeted six
different epitopes (Figure 3B). We previously reported mastercopy (Weiner et al., 1995). Analysis of additional
plasma samples taken at 3 and 82 months postinfectionthat the sequence of the Patr-B1601 restricted epitope
Mutation of CTL Epitopes Predicts HCV Persistence
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confirmed that the same D1449E substitution was fixed Nonstructural Protein 2
CTL lines targeting NS21011, a Patr-A0101 restricted epi-in the quasispecies for a very long period of time (Figure
3B). Two additional epitopes of the six examined also tope in nonstructural protein 2 (LLGPADGMVSK), were
established from the liver of CBO609. The HCV quasi-mutated within the first 3 months of infection. Evolution
of the NS31629 epitope (GAVQNEITL) was complex. The species circulating in this animal displayed a glycine
(G1017) to lysine (K) substitution (LLGPADKMVSK) (Fig-L1637 residue at P9 was replaced with proline (L1637P)
by month 3. However, this substitution was remarkably ure 4D) that prevented CTL recognition of the epitope
(Figure 4E). The second Patr-A0101 positive animalshort-lived, since only 15% of the genomes displayed
the L1637P change by month 10. The remaining 85% (CBO603) did not have detectable NS21011-specific CTL
activity in blood or liver (data not shown) and this epitopecontained the L1637S escape mutation that was com-
pletely and permanently fixed in the quasispecies by did not contain any amino acid substitutions that were
fixed in the quasispecies mastercopy after 5 years ofmonth 16 (Figure 3B). Similar complexity was observed
in the evolution of the second Patr-B1701 restricted HCV-1/910 replication (Figure 4D).
epitope, NS41939 (DAAARVTAIL). Substitutions at P4
(A1942V) and P8 (A1946T) were observed at months 3 Nonstructural Protein 3
and 10, respectively, but by month 16 the P3 (A1941S) The C terminus of the NS3 protein contains a set of
replacement was fixed in the quasispecies mastercopy overlapping epitopes (Figure 5A). One is a Patr-A0101
(Figure 3B). Changes appeared much later in the NS51989 restricted epitope, designated NS31631 (VQNEITLTH),
and E2588 epitopes, at 10 and 21 months postinfection that was still intact in CBO603 after 5 years of virus
respectively (Figure 3B). Only one epitope, E1233, did not replication even though NS31631-specific CTL were re-
change even though CTL-specific for this Patr-B1601 covered from his liver. The other is a Patr-B1701 re-
restricted peptide were detected in his liver at month stricted NS31629 epitope (GAVQNEITL) targeted by animal
82 postinfection (Figure 3B). CH-497 with acute resolving hepatitis C (Figure 2), and
One epitope (NS31444) was mutated at 2.5 months post- two animals, CH-503 and CB0609, with chronic hepatitis
infection in chimpanzee CBO603 (Figure 3C). Mutations C. The C-terminal leucine (L1637) residue was replaced
in two other epitopes (NS41963 and NS51989), detected at with a serine (S) and threonine (T) in CH-503 and
month 63 postinfection, must have occurred gradually CBO609, respectively (Figure 5A). All P9 substituted
because they were not present in a plasma sample col- peptides displayed at least a 400-fold reduction in Patr-
lected at month 4 (Figure 3C). This might be explained B1701 binding (Figure 5B), including the variants that
by the weak or undetectable intrahepatic CTL activity dominated in the early (L1637P) and late (L1637S)
in the liver of this animal during the acute phase of phases of infection in CH-503 (Figures 3B and 5A).
infection (Cooper et al., 1999). NS31629-specific CTL from the blood of CH-609 did not
These results indicated that in contrast to spontane- efficiently recognize target cells pulsed with these P9
ous resolution of hepatitis C, persistent replication of substituted peptides (Figure 5C). It is noteworthy that
the virus was associated with mutation of multiple class the I1635T escape mutation observed in the HCV quasi-
I MHC restricted epitopes. Therefore, we analyzed the species that was cleared from CH-497 (Figure 2) retained
distribution of mutations in epitopes and flanking re- the ability to bind Patr-B1701 (Figure 5B).
gions of the HCV quasispecies from these animals as NS3 contains a second set of overlapping epitopes des-
well as their susceptibility to CTL recognition. All three ignated NS31444 (YTGDFDSVI) and NS31446 (GDFDSVIDC)
shared class I MHC haplotypes (Figure 1A), and these presented by the Patr-B0101 and Patr-B1601 class I mole-
have the potential to present several common epitopes cules, respectively (Kowalski et al., 1996) (Figure 5D). Both
(Figure 1C). were examined for evidence of CTL selection pressure
in the three persistently infected animals.
CH-503
Envelope Glycoprotein 2 As shown in Figure 3B, the Patr-B1601 restricted epitope
The Patr-A0401-restricted epitope E2588 (KHPDATYSR) NS31446 acquired a P4 D1449E substitution within the
located in the E2 glycoprotein (Erickson et al., 1993; first 3 months of infection, and was the only change
Kowalski et al., 1996) was mutated in CH-503 and fixed in this region of the HCV quasispecies almost 7
CBO609, the only two animals that expressed this class years later (Figure 5D). Remarkably, a CTL line cloned
I MHC molecule (Figure 4A). Eight independent E2588- from the liver of CH-503 at the 7 year point recognized
specific CTL lines established from the liver of CH-503 the wild-type NS31446 epitope, but not the D1449E variant
failed to recognize the S595T substituted epitope (i.e., GDFESVIDC) (Figure 5E). This result is consistent
(KHPDATYTR, Figure 4A) expressed by viruses circulat- with our previous observation that NS31446-specific CTL
ing in his plasma. Data for one representative CTL line lines, established after 4, 9, and 24 months of infection,
are shown in Figure 4B. The quasispecies mastercopy did not recognize the P4 substituted variant that repli-
from chimpanzee CBO609 displayed three amino acid cated in his liver (Weiner et al., 1995).
substitutions at positions 4, 6, and 8 of the E2588 epitope CBO603
(KHPSASYAR; Figure 4A). CTL expanded from his pe- Remarkably the same D1449E substitution was also ob-
ripheral blood with the E2588 index peptide did not recog- served in the HCV quasispecies from CBO603 (Figure
nize the triply substituted variant (Figure 4C). CBO603 5D) even though he did not express the Patr-B1601 class
was the only Patr-A0401 negative animal and the E2588 I molecule necessary for presentation of the NS31446 epi-
sequence was still intact after five years of HCV-1/910 tope. However, this mutation interfered with presenta-
tion of the overlapping NS31444 epitope by Patr-B0101.replication (Figure 4A).
Immunity
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Figure 4. HCV-1 E2 and NS2 Sequences in Chronically Infected Chimpanzees
(A) A region of the HCV-1 E2 gene encoding amino acids 570V–623N was amplified using nested PCR primers from plasma of chimpanzees
infected 5 (CBO603 and CBO609) or 7 (CH-503) years earlier with HCV-1/910. Deduced aa sequences and frequencies of individual molecular
clones from each animal are shown. Dashes indicate identity with the published consensus sequence of the HCV-1/910 virus used to infect
the animals. The Patr-A0401 restricted epitope E2588 is outlined and animals that expressed this class I molecule are indicated.
(B) CTL line derived from the liver of CH-503 was tested for lysis of autologous BLCL targets pulsed with varying concentrations of the index
HCV-1 E2588 epitope or peptides representing the dominant viral sequence from their plasma.
(C) CTL line derived from the blood of CBO609 was tested for recognition of E2588 and variant peptides.
(D) A region of the NS2 gene (amino acids 973P–1025L) containing a Patr-A0101 restricted epitope (NS21011) was amplified from the plasma
of all three chronically infected chimpanzees.
(E) A CTL line established from the liver of CBO609 after 5 years of chronic infection was tested for lysis of autologous BLCL targets sensitized
with peptides representing the NS21011 index epitope or the dominant G1017K substituted variant detected in a contemporaneous plasma
sample.
Replacement of D with E at P6 (YTGDFESVI; Figure 5D) NS41939 epitope (i.e., DAAGRVTAIL), which reduced class
I MHC binding by almost 60-fold (Figure 6B). CBO609impaired recognition by NS31444-specific CTL expanded
from peripheral blood (Figure 5F) and caused a 6-fold did not express Patr-A0901 or -B1601 and the NS41963
and NS51989 epitopes that they present were not mutatedreduction in Patr-B0101 binding (Figure 5H).
CBO609 (Figure 6A).
CH-503All HCV genomes sequenced from this second Patr-
B0101 positive animal had an isoleucine to valine re- Mutations fixed in the HCV quasispecies from this ani-
mal were located exclusively in the Patr-B1601 andplacement at P9 of the NS31444 epitope (YTGDFDSVV)
(Figure 5D), which reduced Patr-B0101 binding by ap- -B1701 restricted epitopes (Figure 6A). The Patr-B1701
restricted NS41939 epitope contained an alanine (A1941)proximately 150-fold (Figure 5H). NS31444-specific CTL
were present in his peripheral blood but did not effi- to serine (S) mutation (DASARVTAIL) that resulted in a
14-fold reduction in class I MHC binding (Figure 6B).ciently recognize target cells pulsed with the P9 substi-
tuted peptide (Figure 5G). This substitution was unique amongst those observed
in this study because target cells pulsed with the variant
peptide were efficiently recognized by CTL-specific forNonstructural Proteins 4B and 5A
Next, we examined the region flanking the NS4b/NS5a the HCV-1/910 index peptide (Figure 6C). The K1992R
substitution observed in the Patr-B1601 restrictedprocessing site for mutations in three nonoverlapping
HCV epitopes presented by Patr-A0901, -B1601, and NS51989 epitope (SDFRTWLKA) was more typical in that
it prevented recognition by CTL generated from the liver-B1701 (Figure 6A).
CBO609 of CH-503 after 7 years of chronic infection (Figure 6D).
This animal did not express Patr-A0901 and predictablyViruses from this animal contained an alanine (A1942)
to glycine (G) substitution in the Patr-B1701 restricted the NS41963 epitope was intact (Figure 6A).
Mutation of CTL Epitopes Predicts HCV Persistence
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Figure 5. Sequence of Overlapping HCV-1 NS3 Epitopes in Chronic Hepatitis C
A segment of the NS3 gene encoding amino acids 1605D–1658S was amplified from the plasma of three chronically infected chimpanzees
as described in the legend to Figure 3.
(A) Amino acid sequences of overlapping epitopes NS31629 (Patr-B1701 restricted) and NS31631 (Patr-B0101 restricted) are outlined.
(B) Relative Patr-B1701 binding capacity of the NS31629 parental peptide and variants found in animals with chronic and resolved infections.
The inhibitory concentration 50 (IC50) for each peptide is shown.
(C) A NS31629-specific CTL line generated from the blood of chimpanzee CBO609 was tested for lysis of target cells pulsed with the L1637S
and L1637T variants.
(D) A segment of the NS3 gene encoding amino acids Y1417–R1493 was amplified from the plasma of three chronically infected chimpanzees
as described in the legend to Figure 3. Amino acid sequences of overlapping epitopes NS31444 (Patr-B0101 restricted) and NS31446 (Patr- B1601
restricted) are outlined.
(E) A CTL line established from the liver of CH-503 at 7 years postinfection was tested for lytic activity against autologous target cells pulsed
with the HCV-1 NS31446 index epitope or the D1449E variant (GDFESIVDC) circulating in plasma.
(F) A CTL line generated from the blood of CBO603 was tested for recognition of the NS31444 index and a D1449E substituted peptides.
(G) BLCL target cells sensitized with NS41444 or the I1964V substituted peptide were tested for lysis by an NS41444-specific CTL line generated
from the blood of CBO609.
(H) Relative binding capacity to Patr-B0101 binding of the I1452V or D1449E variants and the NS31444 parental peptide. The inhibitory concentra-
tion 50 (IC50) for each peptide is shown.
CBO603 (L) substitution in the NS41963 epitope (QWLSSECTTPC)
(Figure 6A). CTL lines generated from the liver of thisChimpanzee CB0603 is Patr-A0901 positive and approxi-
mately 50% of the HCV genomes in his plasma at year 5 animal failed to recognize the P3-substituted peptide
(Figure 6E). CBO603 did not express Patr-B1601 so thepostinfection contained a P3 isoleucine (I1964) to leucine
Immunity
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Figure 6. Sequence of NS4b and NS5a Epitopes in Chronic Hepatitis C
(A) Amino acid sequence frequency for three epitopes including NS41939 (Patr-B1701 restricted), NS41963 (Patr-A0901 restricted), and NS51989
(Patr-B1601 restricted).
(B) Reduction in binding to Patr-B1701 by A1942G and A1941S variants detected in chimpanzees CBO603 and CH-503, respectively. Inhibitory
concentration 50 (IC50) values for the parental peptide and two variants are shown.
(C) A CTL line derived from the blood of CH-503 was tested for recognition of the A1941S variant peptide on autologous target cells.
(D) A CTL line derived from the liver of CH-503 was tested for recognition of the K1992R variant peptide on autologous target cells.
(E) A CTL line from the liver of CBO603 was tested for recognition of target cells pulsed with the NS51962 epitope and its I1964L variant.
(F) Target cells transfected with the Patr-B1601 or B1602 class I molecules were pulsed with varying concentrations of the parental NS51989
peptide and tested for lysis by a Patr-B1601 restricted CTL line derived from the liver of chimpanzee CH-503. The concentration of peptide
required to achieve 50 percent specific lysis is indicated.
(G) An NS51989-specific CTL line derived from the blood of CBO603 was tested for lysis of autologous target cells pulsed with the index peptide
or the T1993V variant.
threonine (T1993) to valine (V) mutation in epitope NS51989 Comparison of Mutation Rates in Epitope Versus
Flanking Regions(SDFKVWLKA) (Figure 6A) was unexpected. However,
he did express Patr-B1602, which differs from Patr- If CD8 CTL exert selection pressure then the frequency
of amino acid replacement substitutions should beB1601 by a single amino acid at position 76 of the class
I MHC heavy chain 1 domain (data not shown). Consis- higher in class I MHC restricted epitopes than in flanking
regions or nonrestricted epitopes (i.e., epitopic se-tent with this close similarity, we noted that Patr-B1602
could also present antigen to Patr-B1601 restricted quences in animals that do not express the appropriate
class I MHC molecule). Therefore, we compared theT cells. Indeed, presentation of NS51989 was remarkably
efficient as 10-fold less peptide was required to achieve consensus sequence of the HCV-1/910 challenge virus
(Choo et al., 1992) with RNA genomes circulating in the50% lysis of Patr-B1602 versus Patr-B1601 positive tar-
gets by a Patr-B1601 restricted CTL line from CH-503 three persistently infected animals in order to calculate
the rate of synonymous (dS) and nonsynonymous (dN)(Figure 6F). Most importantly, Patr-B1602 restricted CTL
were expanded from the blood of CBO603 with the NS51989 nucleotide substitutions in epitope and flanking regions.
Within flanking regions, dS was approximately 7-foldpeptide and they failed to recognize target cells sensitized
with the T1993V substituted variant (Figure 6G). higher than dN (0.0272 versus 0.0043) (Table 1). An
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Table 1. Mean Numbers of Synonymous Substitutions per Synonymous Site (dS) and Nonsynonymous Substitutions per Site (dN) in HCV
Epitope and Nonepitope (Remainder) Regions: Comparison with HCV-1/910 Inoculum Consensus Sequence
ds ( SEM) dN ( SEM) p (dS  dN)a
Remainder 0.0272 (0.0350) 0.0043 (0.0013)  0.001
Epitopes:
restricted 0.0808 (0.0349) 0.0639 (0.0154) n.s.
nonrestricted 0.0655 (0.0337) 0.0083 (0.0070) n.s.
P (restrictedremainder)a n.s. 0.002
P (restrictednonrestricted)a n.s. 0.004
a Paired sample T test.
equally high dS:dN ratio was estimated for nonrestricted multiple class I MHC restricted epitopes early in the
course of chronic HCV infection. The role of CD8 CTLepitopes (Table 1). These observations are consistent
with the principal that synonymous mutations are neu- in control of HCV replication is further reinforced by the
statistically significant increase in the nonsynonymoustral, but amino acid replacement substitutions are usu-
ally deleterious and effectively eliminated by selection mutation rate in class I MHC restricted epitopes but not
unrestricted epitopes or flanking sequences of the viralpressure (Nei and Gojobori, 1986). One important excep-
tion to this pattern was noted. dN was approximately genome. These data indicate that at least in chimpan-
zees, amino acid substitutions in class I MHC restrictedone order of magnitude greater in restricted epitopes
(0.0639) than in nonrestricted epitopes (0.0083, p  epitopes are selected and possibly maintained by HCV-
specific CD8 CTL populations that exert positive Dar-0.004) or flanking regions (0.0043, p  0.002) (Table 1).
This statistically significant increase in dN for class I winian selection pressure.
In animal CBO609 (Hulk) mutation of multiple class IMHC restricted epitopes is consistent with the hypothe-
sis that mutations described in Figures 3–6 resulted from MHC restricted epitopes in the acute phase of infection
(Figure 3A) occurred coincident with a strong but nar-positive selection pressure and not chance.
The pattern of mutation within class I MHC restricted rowly focused intrahepatic CTL response (Cooper et al.,
1999). We previously reported NS3- and NS4-specificepitopes is striking, because with few exceptions, the
same nonsynonymous nucleotide substitution was fixed CTL in the liver of this animal between 14 and 36 weeks
postinfection (Cooper et al., 1999), and cytolytic activityin the quasispecies mastercopy for years. Substitutions
at secondary sites within the epitope were rarely ob- was restricted predominantly by the Patr-B1701 class I
molecule (data not shown). Mutation of two Patr-B1701served (Figures 3–6). For instance, the Patr-B1601 re-
stricted epitope NS31446 contained a single substitution restricted epitopes (NS31629 and NS41939) at week 16 post-
infection (Figure 3A) was temporally associated with this(D1449E) in all 20 genomic clones established from the
plasma of CH503 after 7 years of infection (Figure 5D). acute phase CTL activity, and is consistent with early
selection of virus variants that are stable in the liverA pairwise comparison of sequences from all three
chronically infected animals confirmed that dN was not for several years. A total of 4 epitopes in nonstructural
proteins mutated in the first 16 weeks of infection, butstatistically different in class I MHC restricted epitopes
(0.0028), nonrestricted epitopes (0.0031), and flanking exactly how the virus escaped from an apparently multi-
specific CTL response is not clear. Multiple codominant(remainder) regions (0.0034) (Table 2). This indicated that
selection pressure was directional and did not contrib- CTL populations might not be uniformly distributed in
an organ as large as the liver. Under this scenario, theute to ongoing diversification of the virus during several
years of chronic infection. virus is required to escape only a limited set of CTL
populations found in immediate proximity to an infected
hepatocyte or inflamed lobule. Progeny virions couldDiscussion
accumulate mutations in different epitopes through suc-
cessive cycles of infection and replication. If CTL popu-We previously reported a temporal kinetic relationship
between intrahepatic CTL populations and spontaneous lations infiltrated the liver in a staggered fashion, it is
also possible that mutations accumulated serially overresolution of HCV infection in chimpanzees (Cooper et
al., 1999). This study provides evidence for mutation of the first 4 months of infection in CBO609. In support of
Table 2. Mean Numbers of Synonymous Substitutions per Synonymous Site (dS) and Nonsynonymous Substitutions per Site (dN) in HCV
Epitope and Nonepitope (Remainder) Regions: Pairwise Comparison of All HCV Sequence
ds ( SEM) dN ( SEM) p (dS  dN)a
Remainder 0.0170 (0.0034) 0.0034 (0.0008) 0.001
Epitopes:
restricted 0.0237 (0.0094) 0.0028 (0.0002) 0.045
nonrestricted 0.0295 (0.0295) 0.0031 (0.0017) n.s.
P (restrictedremainder)a n.s. n.s.
P (restrictednonrestricted)a n.s. n.s.
a Two sample T test.
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this contention, escape mutations appeared sequen- against these mutants. However, the L1637P substituted
NS41629 peptide failed to bind Patr-B1701 so it is unlikelytially over a period of several weeks to months in the
other two chronically infected animals. For instance, it was targeted by variant-specific CTL. We predict that
some early substitutions, such as L1637P, provided es-amino acid substitutions were observed in five of six
epitopes targeted by CH-503, but they appeared in the cape from the CTL response but were unstable because
they interfered with the function of HCV proteins andquasispecies anywhere from 3 to 21 months postinfec-
tion (Figure 3B). A similar pattern of escape was ob- virus replication.
The relevance of our observations to human HCV in-served in CBO603 (Figure 3C). The gradual accumulation
of escape mutations probably reflects CTL selection fection remains to be established, but key features of
persistent infection are similar in both species. Mostpressure that is focused on a narrow set of the most
dominant epitopes at any given point in time. Narrowly importantly, CD8 T cells required for selection and per-
haps maintenance of mutant viruses are present in manyfocused CTL populations and oscillating patterns of CTL
dominance have been implicated in generation of HIV chronically infected chimpanzees and humans. Multi-
specific CTL circulate in the peripheral blood of bothescape variants (McMichael, 1998) and may also con-
tribute to persistence of HCV. species, but frequencies are usually very low, and un-
conventional methods of antigen-specific expansion areIt is noteworthy that mutation of all class I MHC re-
stricted epitopes was not an absolute requirement for required for their detection (Wong et al., 2001). CTL do
appear to be enriched in the liver, the site of activeHCV persistence. For instance, two Patr-A0101 restricted
epitopes were intact after 5 years of virus replication in virus replication. Two recent studies demonstrated that
HLA-A2 restricted, HCV-specific CTL are not detected inCBO603 (Figures 4D and 5A). In addition, one Patr-
B1601 restricted E1 epitope (E1233) was not changed in the blood of chronically infected humans using soluble,
tetrameric class I MHC molecules, but some are presentchimpanzee CH503 after 7 years of infection (Figure 3B).
Lack of selection pressure against these epitopes might in the liver at frequencies as high as 4% (Grabowska et
al., 2001; He et al., 1999). Enrichment in the liver isbe expected if they are subdominant or interact weakly
with class I MHC or TcR ligands. It is also possible that consistent with successful cloning of intrahepatic HCV-
specific CTL lines from many chronically infected hu-CTL populations targeting these epitopes do not reach
a threshold frequency required for clearance of HCV mans and chimpanzees. In this study, the number of
unique CTL populations cloned from the liver of the(Lechner et al., 2000a) or that they are defective in antivi-
ral function (i.e. cytolysis or cytokine production) chronically infected animals ranged from 2 (CBO609)
to 6 (CH-503). Multispecific CTL populations have also(Lechner et al., 2000b; Sobao et al., 2001). These invari-
ant epitopes could be useful targets for therapeutic vac- been established from the liver of a few chronically in-
fected humans, including one individual who targetedcination to control HCV replication.
Almost all escape mutations detected in the chroni- 5 different HCV epitopes (Wong et al., 1998). Detection of
HCV-specific CTL may be more efficient in chimpanzeescally infected animals were fixed early in the infection.
Consistent with observations in HCV-infected humans than humans because antigens used in screening
assays are matched exactly with the virus used to infect(Chang et al., 1997), they did not diversify further during
several years of follow-up (Table 2). Using conditions the animal. It should also be noted that chronic hepatitis
C is a progressive disease in humans so the presencethat reproducibly expanded CTL-specific for index
HCV-1/910 peptides, we attempted unsuccessfully to or absence of HCV-specific CTL may be influenced by
the duration of infection, genotype of the virus, virusexpand variant-specific CTL in the liver and blood of
these animals. Generation of new variant-specific CTL load, extent of fibrosis or cirrhosis, or other factors.
Animals in this study were infected for 5–7 years, apopulations might be prevented by a lack of adequate
HCV-specific T cell help observed in these chimpanzees relatively short period of time in the natural history of
human HCV infection. Liver histology was usually normaland also in chronically infected humans. Another possi-
bility is that mutant epitopes selectively stimulate or displayed mild periportal inflammation, liver transami-
nases were normal or elevated only slightly above base-expansion of index (wild-type)-specific CTL, a phenom-
enon known as original antigenic sin, which was first line values, and virus loads were fairly stable at 105
(CBO603, CBO609) to 106 (CH-503) genome equivalentsdescribed for antibodies but recently extended to class
I MHC restricted epitopes (Klenerman and Zinkernagel, per ml of plasma. This rather benign course of infection
is also observed in some infected humans, and we spec-1998).
In the present study, we observed multiple, sequential ulate that liver disease might be attenuated by early
mutation of multiple class I MHC restricted epitopes,changes in some epitopes during the first few months
of infection. In chimpanzee CH-503, the L1637P substi- which would otherwise be targeted by immunopatho-
genic CTL.tution in epitope NS31629 appeared first, but was rapidly
replaced by a second variant, L1637S. Two substitutions Mutations in class I MHC restricted HCV epitopes
have been observed in human subjects and many doin the NS41939 epitope (A1942V at month 3 and A1946T
at month 10) were also transiently present in the quasi- impair CTL recognition (Chang et al., 1997; Kaneko et
al., 1997; Tsai et al., 1998). Still, it is uncertain whetherspecies before fixation of the A1941S variant at month
16 postinfection (Figure 3B). Interestingly, the A1946T these mutations result from CD8 T cell selection pres-
sure. Design of human studies to address this issue issubstitution conferred resistance to lysis by NS41939-spe-
cific CTL (data not shown) but did not guarantee survival complex for two important reasons. First, acute hepatitis
C is often clinically silent so early virus isolates and CTLof this virus population in chimpanzee CH-503. Condi-
tions in the first few months of infection may be favorable populations are difficult to obtain. This hinders direct
comparison of epitopes encoded by the infecting virusfor generation of variant-specific CTL that could select
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in a 96-well tissue culture plate with 5 104 irradiated human PBMCand variants that emerge in the first few weeks or months
feeder cells, 50 U/ml of IL 2 and anti-CD3 monoclonal antibodies.of infection. Second, no consistent pattern of HCV epi-
At least 300 independently derived CD8 T cell lines were tested fortope dominance has emerged in humans or chimpan-
recognition of autologous BLCL target cells infected with recombinant
zees. In this study, CTL lines established from the liver vaccinia viruses expressing different regions of the HCV-/910 pol-
of individual animals were used to identify dominant yprotein. 721.221 cells transfected with individual Patr-A, -B, or -C
class I MHC molecules of each animal were used to determineepitopes regardless of class I MHC restriction. Access
class I MHC restriction of the CTL lines. Mapping minimum optimalto liver tissue is restricted in human subjects so HCV
epitopes with synthetic peptides has been described (refs and CMWpeptides presented by the HLA-A2 molecule are often
unpublished data). CTL lines were derived from peripheral blood byused as a surrogate for the entire CTL response. Even
culturing 5  106 PBMC with the HCV peptide (10 M) and tetanus
with these limitations, evidence consistent with immune toxoid (1 g/ml) as a source of T cell help (Cerny et al., 1995).
selection pressure was obtained in one study of chroni- Cells were restimulated on days 7 and 14 with 2  106 irradiated
autologous PBMC pulsed with a 10M concentration of the peptide.cally infected humans who expressed HLA-A2 (Chang
IL 2 (20 U/ml) was added to cultures 3 days after each peptideet al., 1997). Acute phase virus isolates were not avail-
stimulation. CTL activity was assessed on day 21.able from these human subjects so epitope sequences
encoded by the chronic phase viruses were compared
CTL Assayswith those of a single prototype HCV virus, the genotype
B lymphoblastoid cell lines (BLCL) or 721.221 cells transfected with
1a Hutchinson (H77) isolate. HLA-A2 epitopes encoded cloned Patr class I MHC molecules were used as targets. Approxi-
by the chronic phase viruses were more likely to contain mately 1  106 cells were incubated for 1 hr with 50 Ci of 51Cr and
amino acid substitutions if prototype (H77)-specific CTL varying concentrations of peptide epitopes. After washing, 5  103
target (T) cells were cocultured with effector (E) CTL lines at an E:Twere present in blood (Chang et al., 1997). Variants often
ratio of 20:1 for 4 hr. Supernatants (50 l) were harvested into Pack-displayed reduced binding to HLA-A2 and/or impaired
ard Lumaplates and radioactivity was counted in a Wallac Microbetarecognition by prototype-specific CTL. On the other
1420 scintillation instrument.
hand, many prototype HLA-A2 epitopes were un-
changed in these subjects, but this does not necessarily Cloning and Sequencing of HCV Genomes
mean that escape mutations are less important for HCV Chimpanzee blood was collected in EDTA and plasma was frozen
persistence in humans versus chimpanzees. Our find- within 20 min. RNA was extracted from 100 l of thawed plasma
using the RNAEasy protocol and reagents (Qiagen) and cDNA wasings in this animal model suggest that information on the
made as previously described (Weiner et al., 1995). Each region ofsequence of the infecting virus and dominant epitopes
the HCV genome that contained class I MHC restricted epitopestargeted by intrahepatic CTL populations will be critical
was amplified with nested sets of PCR primers designed with Primer
for future studies of escape mutations in humans. Express software (ABI). First round PCR with outside primers was
performed for 35 cycles (94	C for 10 s; 55	C for 30 s, and 72	C for
Experimental Procedures 30 s). Inside nested primers were added to the product of the first
PCR reaction and amplified for an additional 35 cycles as described
Animals above. PCR products were immediately subcloned by thymidine/
Infection of the four chimpanzees enrolled in this study with the adenosine (T/A) ligation into a DNA plasmid (Invitrogen) and se-
HCV-1/910 virus stock has been described in detail (Cooper et al., quenced in both directions using dye terminator chemistry and an
1999; Erickson et al., 1993; Kowalski et al., 1996). Three animals ABI 3100 automated DNA sequencer.
were chronically infected for 5 (CBO603, CBO609) or 7 years (CH-503)
years when enrolled in this study. CBO609 (Hulk) was immunized Class I MHC Molecule Purification and Binding Assay
with recombinant HCV envelope glycoproteins before virus chal- Purification of class I molecules and HCV peptide binding assays
lenge, and CBO603 (Briggsie) was passively immunized with 640 were performed as described(Allen et al., 1998). 721.221 cells trans-
mg of a polyvalent immunoglobulin preparation that contained anti- fected with Patr-B0101 and Patr-B1701 were lysed in 50mM Tris-
E1 and E2 antibodies 24 hr prior to infection (Cooper et al., 1999). HCL, pH 8.5, containing 1% NP-40, 150 mM NaCl, 5 mM EDTA and
CH-503 was immunized by dermal scarification with a recombinant 2 mM PMSF. After filtration supernatants were clarified by centrifu-
vaccinia virus expressing HCV E1 and E2 and then boosted with gation at 10,000g and then passed two to four times over a column
purified envelope glycoproteins before infection (Erickson et al., containing protein A sepharose beads conjugated with the anti-HLA
1993). Class I MHC genotyping of these animals and generation of (A, B, C) antibody W6/32 (Allen et al., 1998). Patr molecules were
Patr class I transfected 721.221 cell lines was reported elsewhere eluted with 50 mM diethylamine in 0.15 M NaCl containing 0.4%
(Cooper et al., 1999; Kowalski et al., 1996). Chimpanzees were n-octylglucoside, pH 11.5. 2.0 M Tris, pH 6.8, was added to the
housed at the New Iberia Research Center (NIRC), New Iberia, Loui- eluate to reduce the pH to 8.0. The eluate was concentrated by
siana, in accordance with “The Guide for Care and Use of Laboratory centrifugation in Centriprep 30 concentrators.
Animals” published by the National Research Council (Anonymous, Binding of HCV peptides to soluble Patr molecules was quantified
1996). The Association accredits NIRC for Assessment and Accredi- by a competitive inhibition assay. Briefly, varying concentrations of
tation of Laboratory Animal Care (AAALAC). Animals were cared HCV peptides and radiolabeled probe peptides (YTGDFDSVI for
for under an experimental protocol approved by the New Iberia Patr-B0101 and YAVQNEITL for Patr-B1701) were coincubated at
Research Center Animal Care and Use Committee. room temperature for 48 hr with purified Patr-B0101 (1M) or Patr-
B1701 (1 nM), human 
2-microglobulin (1 M), and protease inhibi-
Peptides tors. The percent of MHC-bound radioactivity was then determined
Peptides were produced by either Chiron Mimotopes (San Diego, by size exclusion gel filtration chromatography on a TSK2000 col-
California) or Research Genetics (Huntsville, Alabama) using fMoc umn, or by capturing MHC/peptide complexes on Optiplates (Pack-
solid phase chemistry with free amine N termini and free acid C ard) coated with W6/32 mAb, and determining bound cpm in a micro-
termini. Lyophilized peptides were resuspended at a concentration scintillation counter. The inhibitory concentration 50 (IC50) is defined
of 10–20 mg/ml in 10% DMSO and water. as the nM concentration of competitor HCV peptide yielding 50%
inhibition of binding by the radiolabeled probe peptide. Each HCV
peptide was tested in 2–4 independent experiments. Relative bind-Generation of CTL Lines
CTL lines were derived from liver biopsy tissue (Erickson et al., ing capacity of the HCV peptides was calculated by dividing the
IC50 of the test peptide by the IC50 of the index HCV-1/910 peptide.1993). Briefly, T cells recovered from liver homogenates with anti-
CD8 paramagnetic beads were cultured at 10 or 50 cells per well The IC50 of the index peptide was normalized to a value of 1.
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Statistical Analyses al. (1999). Virus-specific cytotoxic T-lymphocyte responses select
for amino-acid variation in simian immunodeficiency virus Env. andPublished methods (Nei and Gojobori, 1986) were used to compute
dS and dN, the number of synonymous nucleotide substitutions per Nef. Nat. Med. 5, 1270–1276.
synonymous site and nonsynonymous nucleotide substitutions per Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder,
site, respectively, in regions of the HCV genome containing class I J.C., Strazzera, A., Chien, D.Y., Munoz, S.J., Balestrieri, A., et al.
MHC restricted epitopes. We performed two separate analyses. (2000). The outcome of acute hepatitis C predicted by the evolution
First, mean dS and mean dN were estimated by comparing the of the viral quasispecies. Science 288, 339–344.
consensus sequence of the HCV-1/910 virus used to infect the ani-
Grabowska, A.M., Lechner, F., Klenerman, P., Tighe, P.J., Ryder, S.,mals with multiple HCV genomes subcloned from their plasma at
Ball, J.K., Thomson, B.J., Irving, W.L., and Robins, R.A. (2001). Directlater time points (5 years postinfection for CBO603 and CBO609, 7
ex vivo comparison of the breadth and specificity of the T cells inyears for CH-503). Second, mean dS and mean dN were calculated
the liver and peripheral blood of patients with chronic HCV infection.for all pairwise comparisons within samples to estimate ongoing
Eur. J. Immunol. 31, 2388–2394.diversification of epitopes in the chronic phase of infection. The
Gruner, N.H., Gerlach, T.J., Jung, M.C., Diepolder, H.M., Schirren,hypotheses that mean dS was equivalent to mean dN in epitopes
C.A., Schraut, W.W., Hoffmann, R., Zachoval, R., Santantonio, T.,restricted by the host, epitopes not restricted by the host, and the
Cucchiarini, M., et al. (2000). Association of hepatitis C virus-specificflanking (remainder) regions were examined using Student’s t test.
CD8 T cells with viral clearance in acute hepatitis C. J. Infect. Dis.
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